Congress Introduces Bold New Legislation to Combat Illegal Fishing, Seafood Fraud
May 11, 2021 16:50 ET
|
Oceana
WASHINGTON, May 11, 2021 (GLOBE NEWSWIRE) -- Today, Rep. Jared Huffman (D-CA) and Rep. Garret Graves (R-LA) introduced the Illegal Fishing and Forced Labor Prevention Act, a comprehensive bill to...
Interpace Biosciences Announces First Quarter 2021 Financial and Business Results
May 11, 2021 16:47 ET
|
Interpace Biosciences, Inc.
● Q1 Revenue of $9.8 Million is Company’s Highest as Combined Molecular Diagnostics and Pharma Services Business ● Q2 Revenue Expected to Exceed $11 million ● On Track to Exceed Full Year 2021...
Correction: EIMSKIP: Operating results for Q1 2021. Published: 2021-05-11 15:31:00
May 11, 2021 16:39 ET
|
Eimskipafelag Islands hf.
Revenue and expenses in column Q1 2021 on slide 10 in the Investor Presentation that was published earlier today, regarding the Company‘s Liner Services were misstated. The numbers have been corrected...
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2021 Financial Results
May 11, 2021 16:39 ET
|
Timber Pharmaceuticals
BASKING RIDGE, NJ, May 11, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the...
Vyant Bio to Present at BioNJ’s 11th Annual BioPartnering Conference
May 11, 2021 16:36 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and...
Recro Announces Proposed Public Offering of Common Stock
May 11, 2021 16:30 ET
|
Recro Pharma, Inc.
EXTON, Pa., May 11, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD:REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Cellectis et Sanofi s’associent pour utiliser l’alemtuzumab en tant qu’agent lymphodéplétant pour les CAR-T allogéniques
May 11, 2021 16:30 ET
|
Cellectis Inc.
PARIS, 11 mai 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (Euronext Growth : ALCLS - Nasdaq : CLLS), une société biopharmaceutique de phase clinique spécialisée dans le développement d’immunothérapies...
EDAP Reports First Quarter 2021 Results and Provides Operational Update
May 11, 2021 16:30 ET
|
EDAP TMS S.A.
Generated record first quarter revenue of EUR 10.3 million (USD 12.4 million), an increase of 35.4% year-over-yearIncreased gross margin year-over-year to 42.4%, contributing to a profitable...
Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T
May 11, 2021 16:30 ET
|
Cellectis Inc.
PARIS, May 11, 2021 (GLOBE NEWSWIRE) -- Cellectis S.A. (NASDAQ: CLLS – Euronext Growth: ALCLS), a clinical-stage biotechnological company employing its core proprietary technologies to develop...
FirstService Appoints Steve Grimshaw to its Board of Directors
May 11, 2021 16:30 ET
|
FirstService Corporation
TORONTO, May 11, 2021 (GLOBE NEWSWIRE) -- FirstService Corporation (TSX: FSV; NASDAQ: FSV) today announced the appointment of Steve H. Grimshaw to its Board of Directors. Mr. Grimshaw’s appointment...
- May 30, 2024 20:00 ET A year of partnerships to drive sustainability in Canadian agriculture
- May 30, 2024 19:36 ET San Diego County Regional Public Safety Agencies Launch Genasys EVAC for Enhanced Emergency Communication